Institutions providing the data: Group Health Cooperative (Washington State), Harvard Vanguard Medical Associates and Harvard Pilgrim Health Care (Massachusetts), HealthPartners (Minnesota), Kaiser Permanente of Colorado, Kaiser Permanente of Northern California, Kaiser Permanente of Southern California, Marshfield Clinic (Wisconsin), and Northwest Kaiser Permanente (Oregon and Washington)
Letter to the Editor
No risk of Guillain–Barré syndrome found after meningococcal conjugate vaccination in two large cohort studies
Article first published online: 6 DEC 2012
Copyright © 2012 John Wiley & Sons, Ltd.
Pharmacoepidemiology and Drug Safety
Volume 21, Issue 12, pages 1359–1360, December 2012
How to Cite
Yih, W. K., Weintraub, E. and Kulldorff, M. (2012), No risk of Guillain–Barré syndrome found after meningococcal conjugate vaccination in two large cohort studies. Pharmacoepidem. Drug Safe., 21: 1359–1360. doi: 10.1002/pds.3353
Prior presentations: These results were presented at a meeting of the Global Collaborative Network for Vaccine Safety Studies organized by the Fondation Mérieux in Annecy, France in March 2011 and at an annual meeting of the Vaccine Safety Datalink in Portland, Oregon in April 2011.
- Issue published online: 6 DEC 2012
- Article first published online: 6 DEC 2012